Stifel Financial posted all-time high Q1 revenue in asset management, despite stock pressure and legal costs this quarter.

Fulcrum Therapeutics, Inc. ( NASDAQ: FULC) Q1 2025 Earnings Conference Call May 1, 2025 8:00 AM ET Alex Sapir – President and Chief Executive Officer Alan Musso – Chief Financial Officer Iain Fraser – ...

Stifel raised its price target for KLA to $770 while oddly maintaining a Sell rating, because logic is optional on Wall ...

A check mark. It indicates that the relevant content has been reviewed and verified by an expert This story has been reviewed by a professional to ensure you get the most accurate and useful ...

FIS Fidelity National Information Services, Inc.